XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities    
Net earnings $ 2,397 $ 2,447
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation 334 319
Amortization of intangible assets 543 467
Asset impairments 163 21
Share-based compensation 195 184
Sale of inventory stepped-up to fair value at acquisition 160 38
Deferred income tax (benefit) expense 191 (21)
Changes in operating assets and liabilities:    
Accounts receivable 524 67
Inventories (373) (362)
Accounts payable (205) (203)
Accrued expenses and other liabilities (78) (224)
Income taxes (577) (236)
Other, net (373) (186)
Net cash provided by operating activities 2,901 2,311
Investing activities    
Acquisitions, net of cash acquired (4,950) (1,598)
Purchases of marketable securities (32) (41)
Proceeds/(Purchases) of short-term investments 750 (750)
Proceeds from sales of marketable securities 40 40
Purchases of property, plant and equipment (493) (489)
Proceeds from settlement of net investment hedges 0 99
Proceeds from the sale of the Spinal Implants business 165 0
Other investing, net (41) 42
Net cash used in investing activities (4,561) (2,697)
Financing activities    
Proceeds (payments) on short-term borrowings, net 1 (32)
Proceeds from issuance of long-term debt 2,979 3,011
Payments on long-term debt (650) (601)
Payments of dividends (963) (914)
Cash paid for taxes from withheld shares (132) (146)
Other financing, net (29) (49)
Net cash provided by (used in) financing activities 1,206 1,269
Effect of exchange rate changes on cash and cash equivalents 58 (4)
Change in cash and cash equivalents (396) 879
Cash and cash equivalents at beginning of period 3,652 2,971
Cash and cash equivalents at end of period $ 3,256 $ 3,850